- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Quadria Group names Rahul Agarwal as Partner at HealthQuad

New Delhi: Quadria Group, a healthcare-focused private equity platform, has announced the appointment of Rahul Agarwal as Partner at HealthQuad, a healthcare-focused growth venture capital platform.
Rahul joins HealthQuad following a long and successful tenure at Quadria Capital, where he most recently served as Managing Director. As part of Quadria since its inception, Rahul has spent over 13 years playing a pivotal role in investments, scaling portfolio companies, fundraising, and, most importantly, delivering successful exits.
In his new role, Rahul will help shape and drive the future fund strategy of HealthQuad and will step in to lead the investment team and committee, majority of who have been instrumental in driving the success of HealthQuad Fund I and Fund II.
With over 18 years of experience in healthcare investing and fund management, Rahul brings a rare combination of institutional investment discipline, operational insight, and deep healthcare expertise across healthcare delivery, pharma and digital health. He has executed investment and exit transactions of over US$1.5b across India, Southeast Asia and US during his stint at Quadria at prior to that at Religare Global Asset Management and Evolvence India Fund.
This appointment comes at a strategic moment for HealthQuad, which recently announced the launch of HealthQuad Fund III, targeting a raise of up to US$300 million (including a greenshoes of US$100 million). As a successor to Funds I and II, Fund III aims to build on HealthQuad’s proven track record of backing pioneering healthcare ventures that have significantly enhanced access, affordability, and quality of healthcare across India.
Quadria Group intends to announce few more senior appointments to strengthen the investment and the operating capability at HealthQuad.
Sunil Thakur, Co-founder of HealthQuad, added, “Rahul has been an integral force in shaping Quadria’s growth journey, earning deep trust and respect across the organization. His move to HealthQuad represents not just a strategic transition, but a powerful affirmation of our long-term vision. With his deep familiarity with the HealthQuad team and portfolio companies, Rahul’s integration will ensure seamless continuity while elevating the platform’s institutional strength.”
Rahul Agarwal, Partner at HealthQuad, shared, “HealthQuad represents the future of healthcare investing—driven by innovation, supported by a strong ecosystem, and grounded in the values of impact and scalability. I’m excited to join this exceptional team at a pivotal point in its journey. With Fund III, we have a unique opportunity to institutionalize early-stage healthcare investing in India and build category-defining companies. I look forward to contributing with the same passion and purpose that have defined my journey at Quadria.”
Rahul’s appointment comes as HealthQuad expands its strategic focus across high-growth sectors such as healthtech, medtech, biopharma, and digitally enabled care delivery models, while leveraging Quadria’s global investor base and healthcare ecosystem.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751